Log in or Sign up for Free to view tailored content for your specialty!
Cardiology News
Decision support tools do not reduce disparities in cardiovascular care
Clinical decision support tools were not associated with reductions in racial, ethnic and gender disparities in CVD prevention metrics among primary care practices, according to researchers.
GI societies: ‘Little or no data’ linking GLP-1 agonists to safety issues during endoscopy
In response to safety concerns surrounding sedation for patients prescribed glucagon-like peptide-1 receptor agonists, the AGA, AASLD, ACG, ASGE and NASPGHAN encourage gastroenterologists to follow “best practices” for endoscopy procedures.
Log in or Sign up for Free to view tailored content for your specialty!
Premature CV death from air pollution declines while years living with disability rises
An analysis of the Global Burden of Disease study showed that despite decreasing rates of CV death attributable to air pollution, the number of years living with disability increased from 1990 to 2019, especially among men.
Combinations of aerobic, muscle-strengthening activities reduce risk for mortality
Adults who completed at least some levels of moderate and vigorous aerobic physical activity and the recommended levels of muscle-strengthening activity reduced their risks for all-cause, CVD and cancer mortality, a recent study found.
Study links TV viewing in childhood to metabolic syndrome as adult
A long-running cohort study found an association between frequent television viewing as a child and developing metabolic syndrome as an adult, according to results reported in Pediatrics.
‘Lipid paradox’ may obscure cardiovascular risk in patients with inflammatory disease
AUSTIN, Texas — Providers should carefully consider the “lipid paradox” when monitoring cardiovascular risks in patients with rheumatic inflammatory diseases, noted a presenter at the 2023 Rheumatology Nurses Society annual conference.
Topline data show semaglutide cuts CV risk by 20%: SELECT
Compared with placebo, injectable semaglutide 2.4 mg reduced risk for major adverse CV events by 20% for people with overweight or obesity and established CVD, according to topline data from the SELECT study.
Top in cardiology: Effects of alcohol on blood pressure; ‘magic number’ of daily steps
Any level of alcohol consumption was associated with an increase in systolic blood pressure, with data showing no indication of an exposure-effect threshold, according to researchers.
Q&A: Space-grown stem cells may hold key to understanding heart function in microgravity
With the rise of commercial spaceflight and astronauts’ stays aboard the International Space Station becoming longer, researchers seek to understand the impact of microgravity in low-Earth orbit on the function of the heart.
Healio partners with CMHC for annual congress
Together with Healio, Cardiometabolic Health Congress will welcome providers across many medical specialties to learn from pioneers and visionaries in the cardiometabolic health movement this fall.